Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy
Clinical trial NCT02485470 · TERMINATED
Trial details
- NCT number
- NCT02485470
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-10-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.